Pediatrics · MU Sofia

3. Chronic diseases of pulmonary system in children.

Covers the main chronic lung diseases seen in children: cystic fibrosis, primary ciliary dyskinesia, bronchiectasis from other causes, bronchopulmonary dysplasia and congenital lung malformations. A table sets out how cystic fibrosis affects each organ, and another compares the malformations. It also outlines diagnosis and treatment for each condition and lists other causes to consider.

Inside: 7 sections · 2 tables · 16 flashcards · 4 min

Topic 3 of 30 in the MU Sofia syllabus for Pediatrics (Medicine, Year 5). The free AceMed note covers it in 7 sections, about 407 words (4 min of reading), with 16 flashcards.

In this note

  1. Introduction
  2. Cystic fibrosis (CF)
  3. Primary ciliary dyskinesia (PCD)
  4. Bronchiectasis not caused by CF
  5. Bronchopulmonary dysplasia (BPD)
  6. Congenital lung malformations
  7. Other causes to think of

Introduction

A chronic lung disease in a child usually shows as a wet cough lasting more than 4 weeks, recurrent chest infections, poor growth or finger clubbing. The main causes are cystic fibrosis, primary ciliary dyskinesia, bronchiectasis from other causes, bronchopulmonary dysplasia, and congenital lung malformations.

Cystic fibrosis (CF)

The commonest lethal autosomal recessive disease in white populations (about 1 in 2500–3500 births). Mutations in the CFTR gene (chromosome 7; commonest F508del) break a chloride channel in epithelial cells. Secretions become thick and sticky, and blocked ducts and airways become inflamed and infected.

Diagnosis

  • Newborn screening: raised immunoreactive trypsinogen (IRT) in the heel-prick blood, then CFTR mutations.
  • Sweat test chloride ≥ 60 mmol/L confirms CF (30–59 is borderline).
  • Genetic testing; faecal elastase for the pancreas.

Treatment

  • Daily airway clearance physiotherapy and exercise; inhaled dornase alfa and hypertonic saline to thin mucus.
  • Antibiotics for exacerbations; inhaled tobramycin or colistin against Pseudomonas; azithromycin.
  • CFTR modulators (elexacaftor–tezacaftor–ivacaftor) correct the faulty protein for most mutations and have changed the outlook.
  • Pancreatic enzymes with every meal, high-calorie high-fat diet, vitamins A, D, E, K, extra salt. Lung transplant at end stage.

Continue reading free

The whole note, all 7 sections, is free with an AceMed account, with its 16 flashcards. Premium adds flashcard recall, highlights and Ask AI.